Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peripheral muscle dysfunction in chronic obstructive pulmonary disease.

F Maltais1, P LeBlanc, J Jobin

  • 1Centre de Pneumologie, Hôpital Laval, Institut Universitaire de Cardiologie et de Pneumologie de l'Université Laval, Université Laval, Québec, Canada.

Clinics in Chest Medicine
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.

Respiratory medicine·2024
Same author

The ESCRT-0 subcomplex component Hrs/Hgs is a master regulator of myogenesis via modulation of signaling and degradation pathways.

BMC biology·2021
Same author

Salbutamol use in relation to maintenance bronchodilator efficacy in COPD: a prospective subgroup analysis of the EMAX trial.

Respiratory research·2020
Same author

Effects of High-Intensity Interval Running Versus Cycling on Sclerostin, and Markers of Bone Turnover and Oxidative Stress in Young Men.

Calcified tissue international·2019
Same author

Amyotrophic lateral sclerosis in Huntington disease gene carrier.

Revue neurologique·2017
Same author

Ethno-Cultural Considerations in Cardiac Patients' Medication Adherence.

Clinical nursing research·2016

Peripheral muscle dysfunction is a common complication in COPD, leading to disability and mortality. While potentially treatable with exercise and nutrition, incomplete success necessitates further research into underlying mechanisms for better therapies.

Area of Science:

  • Pulmonary Medicine
  • Exercise Physiology
  • Muscle Biology

Background:

  • Peripheral muscle dysfunction is a frequent systemic complication in moderate to severe Chronic Obstructive Pulmonary Disease (COPD).
  • This dysfunction contributes significantly to patient disability, handicap, and premature mortality.
  • Unlike largely irreversible lung impairment, peripheral muscle dysfunction is considered potentially remediable.

Purpose of the Study:

  • To highlight the significance of peripheral muscle dysfunction in COPD.
  • To underscore the need for a deeper understanding of its underlying mechanisms.
  • To guide the development of innovative and more effective therapeutic strategies.

Main Methods:

  • Review of existing literature on COPD-related peripheral muscle dysfunction.

Related Experiment Videos

  • Analysis of current therapeutic interventions and their limitations.
  • Identification of knowledge gaps in the mechanistic understanding.

    • Main Results:

    • Peripheral muscle dysfunction is a key factor in COPD morbidity and mortality.
    • Current treatments like exercise, nutrition, oxygen, and anabolic drugs offer incomplete therapeutic success.
    • A comprehensive understanding of the mechanisms driving muscle dysfunction is lacking.

    Conclusions:

    • Peripheral muscle dysfunction is a critical, yet incompletely understood, aspect of COPD.
    • Further research into the mechanisms of peripheral muscle dysfunction is essential.
    • Developing novel therapeutic strategies requires a mechanistic-based approach for improved patient outcomes.